 |
인쇄하기
취소
|
Korea suspends sales of oral ketoconazole products
The Ministry of Food and Drug Safety (MFDS), Korea’s health regulator, said on Thursday it would suspend sales of oral ketoconazole pills, after potentially fatal liver injury, risk of drug interactions and adrenal gland problems were linked to their use.
The ban came after the U.S. Food and Drug Administration (FDA) on July 26 took several actions related to Nizoral (ketoconazole) oral tabl...
The ban came after the U.S. Food and Drug Administration (FDA) on July 26 took several actions related to Nizoral (ketoconazole) oral tabl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.